Stockreport

CervoMed Announces Addition to Russell 2000® and Russell 3000® Indexes

CervoMed Inc.  (CRVO) 
PDF BOSTON, June 24, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, [Read more]